Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease

Establishment of combined diagnostic models of Alzheimer's disease

Plasma Aβ biomarker for early diagnosis and prognosis of

Jeroen VANBRABANT, Development Scientist, Doctor of Philosophy, ADx NeuroSciences, Gent, R&D

PDF) Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline

PDF) Lipids as Early and Minimally Invasive Biomarkers for Alzheimer's Disease

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's

Clinically accurate diagnosis of Alzheimer's disease via

Frontiers Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ

Contrasting methods to measure plasma Aβ. Two common methods to